Replication Medical

Replication Medical is a medical device company specializing in the development of implantable products based on its proprietary hydrogel platform technology. Founded in 2000 and headquartered in Cranbury, New Jersey, the company focuses on treating degenerative spinal diseases and providing surgical solutions in orthopedics, neurosurgery, and vascular surgery. Its flagship products include GelStix for nucleus augmentation and EnGuard for vascular protection during spinal surgery. The company's hydrogels are designed to be biomimetic, offering high biocompatibility, shape memory, and mechanical strength. Replication Medical has received significant funding from partners like Abbott Spine and grants from the NIH to advance its clinical programs.